BR9909679A - Proteìna tao quinases e processos para seu uso - Google Patents
Proteìna tao quinases e processos para seu usoInfo
- Publication number
- BR9909679A BR9909679A BR9909679-0A BR9909679A BR9909679A BR 9909679 A BR9909679 A BR 9909679A BR 9909679 A BR9909679 A BR 9909679A BR 9909679 A BR9909679 A BR 9909679A
- Authority
- BR
- Brazil
- Prior art keywords
- processes
- kinases
- protect
- mitogen
- presented
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 108091000080 Phosphotransferase Proteins 0.000 title abstract 2
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 102100023275 Dual specificity mitogen-activated protein kinase kinase 3 Human genes 0.000 abstract 1
- 101001115394 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 3 Proteins 0.000 abstract 1
- 102000043136 MAP kinase family Human genes 0.000 abstract 1
- 108091054455 MAP kinase family Proteins 0.000 abstract 1
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003226 mitogen Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000026731 phosphorylation Effects 0.000 abstract 1
- 238000006366 phosphorylation reaction Methods 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
- 230000019491 signal transduction Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/060,410 US6165461A (en) | 1998-04-14 | 1998-04-14 | Tao protein kinases and methods of use therefor |
| PCT/US1999/008165 WO1999053076A1 (en) | 1998-04-14 | 1999-04-14 | Tao protein kinases and methods of use therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9909679A true BR9909679A (pt) | 2000-12-19 |
Family
ID=22029289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9909679-0A BR9909679A (pt) | 1998-04-14 | 1999-04-14 | Proteìna tao quinases e processos para seu uso |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6165461A (enExample) |
| EP (1) | EP1071787A1 (enExample) |
| JP (1) | JP2002515223A (enExample) |
| CN (1) | CN100374568C (enExample) |
| AU (1) | AU758731B2 (enExample) |
| BR (1) | BR9909679A (enExample) |
| CA (1) | CA2325824A1 (enExample) |
| WO (1) | WO1999053076A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6165461A (en) | 1998-04-14 | 2000-12-26 | Board Of Regents, University Of Texas System | Tao protein kinases and methods of use therefor |
| US7078182B1 (en) | 1998-04-14 | 2006-07-18 | Board Of Regents, The University Of Texas System | TAO protein kinase polypeptides and methods of use therefor |
| US7148330B2 (en) * | 1999-07-30 | 2006-12-12 | Schering Corporation | Binding compounds for IL-27 |
| US6806293B1 (en) | 2001-03-12 | 2004-10-19 | Darley Pharmaceuticals Ltd | Use of pheromone compounds having MAP kinase modulating activity |
| WO2002072809A1 (en) * | 2001-03-12 | 2002-09-19 | Alydar Pharmaceuticals, Inc. | Screening non-peptide, non-steroid invertebrate pheromone compounds for mitogen-activated protein kinase modulating activity |
| CA2449289A1 (en) * | 2001-06-05 | 2002-12-12 | Exelixis, Inc. | Gfats as modifiers of the p53 pathway and methods of use |
| CA2454514A1 (en) * | 2001-08-06 | 2003-02-20 | Exelixis, Inc. | Sphks as modifiers of the p53 pathway and methods of use |
| CA2460806A1 (en) * | 2001-12-13 | 2003-06-26 | Exelixis, Inc. | Taojiks as modifiers of the beta-catenin pathway and methods of use |
| WO2004012817A2 (en) * | 2002-07-31 | 2004-02-12 | Kylix B.V. | Use of genes identified to be involved in tumor development for the development of anti-cancer drugs |
| US7282479B2 (en) * | 2003-03-31 | 2007-10-16 | Ttc Co., Ltd. | Hyperthermia agent for malignant tumor comprising cytokine and magnetic fine particles |
| EP1514558A1 (en) * | 2003-09-15 | 2005-03-16 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Use of MARKK or MARKK antagonists for the treatment of pathologies characterised by increased or reduced phosphorylation of MARK or tau protein |
| AU2006262324A1 (en) * | 2005-06-20 | 2007-01-04 | Exelixis, Inc. | GALK1s as modifiers of the PTEN/AKT pathway and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998000539A2 (en) * | 1996-07-03 | 1998-01-08 | Chiron Corporation | (mitogen-activated protein kinase) kinase-3 (mkk3) interacting protein (mip) |
| WO1999002699A1 (en) * | 1997-07-08 | 1999-01-21 | Cadus Pharmaceutical Corporation | Kds protein kinase molecules and uses related thereto |
| US6165461A (en) | 1998-04-14 | 2000-12-26 | Board Of Regents, University Of Texas System | Tao protein kinases and methods of use therefor |
-
1998
- 1998-04-14 US US09/060,410 patent/US6165461A/en not_active Expired - Fee Related
-
1999
- 1999-04-14 EP EP99917495A patent/EP1071787A1/en not_active Withdrawn
- 1999-04-14 JP JP2000543623A patent/JP2002515223A/ja active Pending
- 1999-04-14 BR BR9909679-0A patent/BR9909679A/pt not_active Application Discontinuation
- 1999-04-14 AU AU35605/99A patent/AU758731B2/en not_active Ceased
- 1999-04-14 WO PCT/US1999/008165 patent/WO1999053076A1/en not_active Ceased
- 1999-04-14 CN CNB99806761XA patent/CN100374568C/zh not_active Expired - Fee Related
- 1999-04-14 CA CA002325824A patent/CA2325824A1/en not_active Abandoned
-
2000
- 2000-11-27 US US09/723,458 patent/US6586242B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002515223A (ja) | 2002-05-28 |
| WO1999053076A9 (en) | 2001-03-15 |
| EP1071787A1 (en) | 2001-01-31 |
| WO1999053076A1 (en) | 1999-10-21 |
| CA2325824A1 (en) | 1999-10-21 |
| AU3560599A (en) | 1999-11-01 |
| AU758731B2 (en) | 2003-03-27 |
| US6586242B1 (en) | 2003-07-01 |
| CN100374568C (zh) | 2008-03-12 |
| US6165461A (en) | 2000-12-26 |
| CN1303435A (zh) | 2001-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK552684A (da) | Desulfatohirudiner samt deres fremstilling og anvendelse | |
| BR0316234A (pt) | Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos | |
| BR9909679A (pt) | Proteìna tao quinases e processos para seu uso | |
| TR199903331T2 (xx) | Farnesil protein transferas engelleyicileri. | |
| BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| ATE108668T1 (de) | Transdermale applikation von 2-amino-6-n- propylamino-4,5,6,7-tetrahydrobenzothiazol. | |
| BR0211863A (pt) | 1-alquil ou 1-cicloalquiltriazolo[4,3a]quinazolin-5-onas como inibidores da fosfodiesterase | |
| MXPA04003668A (es) | Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos. | |
| BRPI0007487B8 (pt) | difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase | |
| PL342078A1 (en) | Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas | |
| NL193762B (nl) | Microsmeltveiligheid van het chiptype. | |
| ATE529109T1 (de) | Hemmung der p38 kinase aktivität durch substituierte heterocyclische harnstoffe | |
| BR0113176A (pt) | Compostos biciclo-pirazol, composições farmacêuticas compreendendo os compostos, uso dos compostos na fabricação de medicamentos, processos para a preparação dos compostos, coleção quìmica combinatória e métodos para o tratamento de mamìferos incluindo humanos utilizando os compostos | |
| BR9810955A (pt) | "4-5-diaril imidazóis 2-substituìdo" | |
| FI935585A0 (fi) | Pyrrolopyrimidiner | |
| NO308798B1 (no) | Proteinkinase-C-hemmere, anvendelse av samme for fremstilling av farmasøytika samt farmasøytisk formulering omfattende samme | |
| TR200002617T2 (tr) | Aril ve heteroaril sübstitüentli heterosiklik üreler kullanılarak RAF kinazın inhibe edilmesi | |
| BR9907270A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto | |
| TR199800012T1 (xx) | Piroloprimidinler ve preparasyon i�in tatbikler. | |
| BR0107943A (pt) | Sìtios de entrada de ribossoma internos sintéticos e métodos de identificar os mesmos | |
| BR9814080A (pt) | Uso de compostos para atividade anti-prurìtica | |
| TR200101756T2 (tr) | Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller. | |
| ATE107859T1 (de) | Verwendung von antiprogestomimetika zur stimulierung des eisprungs. | |
| DE3852625D1 (de) | Vektoren und Verbindungen zur Expression von Zymogen-Formen von menschlichem Protein C. | |
| DK203189D0 (da) | Biologiske materialer, fremgangsmaader til fremstiling af biologiske materialer samt anvendelse af materialerne til terapeutiske formaal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. PORTANTO, INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM OS ARTIGOS 8O, 10 (VIII), 10 (IX), 13, 18 (III), 24 E 25 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |